Aim: As EAs with T1D become independent in self-care, they often confront diabetes management challenges. We sought to assess ways in which EAs seek information when faced with uncertainty in their diabetes care.

Methods: EAs (ages 18-25) with T1D participated in a qualitative study regarding their experiences of transitioning to self-management. In semi-structured interviews, participants were asked, “Tell me more about how you look for answers when you’re not sure what to do [in your diabetes management].” De-identified interview transcripts were analyzed using directed qualitative content analysis.

Results: Interviews were conducted with 24 participants, mean age 21.5 ± 1.8 years; 46% were male, 42% female, 13% trans/non-binary; 75% identified as non-Hispanic white. Mean age at diagnosis was 10.0 ± 6.3 years; 71% reported A1c <8%. Many used technology with 83% using pumps and 96% using CGM. Two main themes emerged regarding information sources, endorsed roughly equally by participants: (1) Seek out people with lived experience of T1D (either personal acquaintances or online) as the best knowledge source, (2) Identify people with formal education/training about diabetes management (e.g. clinical providers, device companies) for most reliable information. Two sub-themes emerged regarding verification of information from non-medical professionals: (1a) Look for agreement across multiple sources, and (1b) Differentiate between universal and individualized aspects of diabetes management.

Conclusion: While many EAs with T1D seek others with personal lived experience of T1D to problem-solve self-care challenges, others prefer to rely on people with formal education/training. Clinicians/educators should consider ways to offer virtual opportunities for EAs to seek support for their self-care between clinical encounters. Online forums may offer a way for EAs with T1D to connect. Providers can help EAs learn how to evaluate the reliability of their information sources.

Disclosure

K.R. Shank: None. R.J. Vitale: None. N. Asher: None. B. Katyal: None. K. Garvey: Advisory Panel; Sanofi. L.M. Laffel: Consultant; Dexcom, Inc. Advisory Panel; Medscape, Medtronic, Vertex Pharmaceuticals Incorporated. Consultant; Novo Nordisk. Advisory Panel; Lilly Diabetes, Provention Bio, Inc., Sanofi-Aventis U.S., Janssen Pharmaceuticals, Inc., MannKind Corporation.

Funding

Endocrine Fellows Foundation; NIH T32DK007529; NIH P30DK036836; Iacocca Foundation Senior Postdoctoral Fellowship

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.